WHO’s technology transfer hub in Africa
How Big Pharma is sidestepping it
It is acceptable that companies which develop and make these products should do so at reasonable margin. But leading mRNA companies are now reporting extreme profits.
David Richard Walwyn - Pharmaceutical company Moderna announced on 7 March 2022 that it would develop a site in Kenya to manufacture Covid-19 vaccines. The company holds much of th
...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 12:00.
Comments
Namibian Sun
No comments have been left on this article